Sponsored by The Postgraduate Institute for Medicine and CME Incite.
This activity is supported by independent educational grants from Forest Laboratories, Inc. and Genentech, Inc.
Specialty: Psychiatric Medicine
Release date: April 4, 2014
Valid through: April 4, 2015
This activity has been developed for psychiatrists, primary care physicians, and other health care professionals who treat patients with or at risk for developing schizophrenia.
This activity consists of two educational modules:
Module 1 will focus on psychiatrist education and is titled Negative Symptoms in Schizophrenia: Early Detection, Current Management, and Emerging Treatment Strategies.
The purpose of this module is to offer psychiatrists and other health care professionals who manage patients with schizophrenia the tools to better identify positive and negative symptoms of the disease and understand emerging therapies and the pathophysiology of schizophrenia such that they will be able to provide the best possible care to each patient.
Module 2 will focus on primary care education and is titled Reaching a Vulnerable Patient Population: Optimizing the Care of Schizophrenia in Primary Care.
The purpose of this module is to offer primary care physicians and other health care professionals who manage patients with schizophrenia the tools to diagnose the disease, understand current and emerging treatment options, and implement a multidisciplinary approach to improve care.
At the end of each module, there is a bonus section that includes:
This program consists of 2 continuing education activites.